These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8226403)

  • 1. In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion.
    Souza LC; Maranhão RC; Schreier S; Campa A
    J Antimicrob Chemother; 1993 Jul; 32(1):123-32. PubMed ID: 8226403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion.
    Souza LC; Campa A
    J Antimicrob Chemother; 1999 Jul; 44(1):77-84. PubMed ID: 10459813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study.
    Souza LC; Saldiva PH; Campa A
    Exp Toxicol Pathol; 2000 May; 52(2):169-75. PubMed ID: 10965993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and toxicity of amphotericin B/triglyceride emulsion formulations.
    Lance MR; Washington C; Davis SS
    J Antimicrob Chemother; 1995 Jul; 36(1):119-28. PubMed ID: 8537259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.
    Kirsh R; Goldstein R; Tarloff J; Parris D; Hook J; Hanna N; Bugelski P; Poste G
    J Infect Dis; 1988 Nov; 158(5):1065-70. PubMed ID: 3183418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amphotericin B associated with a lipid emulsion on the oxidative burst of human polymorphonuclear leukocytes.
    Marzzullo L; Souza LC; Campa A
    Gen Pharmacol; 1997 Feb; 28(2):203-7. PubMed ID: 9013195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films.
    Cossu A; Wang MS; Chaudhari A; Nitin N
    Int J Pharm; 2015 Sep; 493(1-2):233-42. PubMed ID: 26231107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity.
    Egito ES; Araújo IB; Damasceno BP; Price JC
    J Pharm Sci; 2002 Nov; 91(11):2354-66. PubMed ID: 12379920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product.
    Damasceno BP; Dominici VA; Urbano IA; Silva JA; Araújo IB; Santos-Magalhães NS; Silva AK; Medeiros AC; Oliveira AG; Egito ES
    J Biomed Nanotechnol; 2012 Apr; 8(2):290-300. PubMed ID: 22515080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
    Chavanet P; Duong M; Buisson M; Hamel H; Dubois C; Bonnin A; Portier H
    J Antimicrob Chemother; 1997 Mar; 39(3):427-30. PubMed ID: 9096196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers.
    Lamb KA; Washington C; Davis SS; Denyer SP
    J Pharm Pharmacol; 1991 Jul; 43(7):522-4. PubMed ID: 1682471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats.
    LeBrun M; Grenier L; Bergeron MG; Thibault L; Labrecque G; Beauchamp D
    Antimicrob Agents Chemother; 1999 Mar; 43(3):520-4. PubMed ID: 10049261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients.
    Sorkine P; Nagar H; Weinbroum A; Setton A; Israitel E; Scarlatt A; Silbiger A; Rudick V; Kluger Y; Halpern P
    Crit Care Med; 1996 Aug; 24(8):1311-5. PubMed ID: 8706484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution.
    Randall SR; Adams LG; White MR; DeNicola DB
    Am J Vet Res; 1996 Jul; 57(7):1054-8. PubMed ID: 8807021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
    Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
    Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.